Indian Drug Firms
-
Maiden Pharmaceuticals responsible for the deaths of 66 children, says Gambia Parliamentary panel
The select committee recommended that the Indian medicine manufacturer should be blacklisted and its products be banned in West African nation.
Scroll Staff
-
Maiden Pharma seeks to reopen factory after drug regulator says no contaminants in cough syrups
On Tuesday, the DCGI said that the WHO drew a premature link between the deaths of 66 children in The Gambia and the cough syrups made by Haryana-based company.
Scroll Staff
-
WHO drew premature link between deaths of children in Gambia and India-made cough syrups, says DCGI
Test reports have shown that the syrups were not contaminated with diethylene glycol or ethylene glycol, the drug regulator said.
Scroll Staff
Trending
-
‘No educated person will vote for the BJP. What is the point of studying if we do not get jobs?’
-
What did Vinayak Damodar Savarkar think about Dalits praying in temples and eating with Brahmins?
-
The BJP wants an Opposition-free Gujarat. But some are putting up a fight
-
View from the Margins: A Miya poet on how Hindutva's rise has scarred his community
-
Start the week with a film: Why ‘Manjummel Boys’ was a blockbuster
-
Haryana stops production of cough syrups linked to deaths of 66 children in The Gambia
State health minister said that 12 flaws were found during an inspection of the medicines and their manufacturing process.
Scroll Staff
-
Gambia Police begin probe into deaths of children linked to India-made cough syrups
President Adama Barrow’s office said that the foreign ministry had been asked to communicate the government’s ‘most profound concern’ to the Indian embassy.
Scroll Staff
-
Firm linked to Gambia deaths failed to meet standards for other drugs four times in India this year
Meanwhile, the Food and Drug Administration in Haryana said it was preparing to test samples of the four syrups, which were made for export.
Tabassum Barnagarwala
Video
-
Watch: South Korean band performs Rabindra Sangeet accompanied by traditional Korean instruments
-
Watch: This man fused hip-hop with Bharatnatyam to dance to Shakira’s ‘Hips Don’t Lie’
-
Watch: Comedian hilariously mimics different types of announcements at railway stations
-
Eco India: A new buzzword for a protein rich animal feed: Insect farming
-
Eco India, Episode 259: How future-proof innovations can revolutionize the way we protect nature
-
Thalassemia patients complain of shortage of life-saving drug that removes excess iron from blood
However, Novartis, the sole manufacturer of the medicine, says that the stock is sufficient.
Priyanka Vora
-
Is 74% foreign direct investment in brownfield pharma really bad for Indian generics?
The new policy can keep Indian companies competitive and bring investment into the country.
Prashant Reddy